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1. Introduction 
Exposure to a variety of chemicals is a hazard of daily life. Some of these chemicals have 
teratogenic potency and may lead to social problems. As an example, thalidomide was 
prescribed as a sedative and for morning sickness in the late 1950s and caused serious 
embryonic effects worldwide. To avoid these problems, the development of efficient 
techniques for the detection of teratogenic substances contained in various chemical 
compounds is desired. Detection of teratogenic effects using various experimental animals is 
only partially effective because different phenotypes occur among species. Therefore, 
effective methods for the detection of teratogenic factors must be based on their molecular 
mechanisms. However, knowledge of the molecular mechanisms that lead to the different 
phenotypes caused by teratogenic factors is limited, and useful molecular markers for these 
factors are not known. 
Approximately 30,000 genes in higher organisms are expressed under strict control. This 
regulation of expression is mainly dependent on transcription factor networks. In higher 
organisms, there are about five hundred transcription factors that contain a DNA-binding 
domain and cooperate in the regulation of the expression of downstream genes. 
Alterations in these regulatory mechanisms result in a variety of problems. In the case of 
teratogenic factors, abnormal morphogenesis is one of the common findings in exposed 
embryos. Developmental abnormalities including skeletal malformations, cleft palates, 
neural tube defects, and cardiovascular anomalies have been found to have a  
similar causative mechanism, which was revealed in loss- or gain-of-function studies of  
the transcription factors involved in morphogenesis. The information from genetic 
analyses is important for the understanding of the molecular mechanism of teratogenic 
effects.  
The present chapter discusses the transcription factors involved in morphogenesis (Hox, T-
box family, and other homeo-box genes) and the deleterious agents that lead to congenital 
malformations, and the link between them is explored. We also present recent findings from 
our group and provide guidelines for the prevention of the risks associated with 
environmental contaminants. In addition, we speculate on the molecular mechanisms of 
congenital malformation.  
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2. Transcription factors for development  
The individual cells that make up multi cellular organisms acquire a wide variety of 
positional information cues from body axes. This local information leads to the formation of 
tissues and organs and is essential for the maintenance of homeostasis. There are three 
fundamental axes in multi cellular organisms: anterior-posterior, dorso-ventral, and 
proximal-distal. Abnormalities in body axis formation caused by genetic or external factors 
can lead to the development of lesions. Certain transcription factors play critical roles in 
body axis patterning, along with a wide variety of diffusible factors such as growth factors, 
BMPs, sonic hedgehog. 
In this section, we refer to several transcription factors involved in body axis formation. 
2.1 Hox genes 
2.1.1 Overview of Hox genes 
Hox genes encode transcription factors that play important roles in the process of 
morphogenesis along the anterior-posterior axis of the body. In the early 1900s, Morgan and 
Bridges found abnormal body plan mutants such as the replacement of antennae with legs 
in Drosophila melanogaster. These morphological abnormalities may have been caused by 
alterations in the expression of genes that contain a characteristic sequence (homeo-box), 
which were described in 1970. The homeo-box sequence encodes 61 amino acids designated 
as the homeo-domain and composed of a helix-turn-helix. Through the activity of this 
homeo-domain, Hox proteins bind a core consensus sequence (5’-TAAT-3’) in target genes 
and function as transcriptional activators or repressors. In the regulation of the expression of 
various downstream genes, Hox proteins function as monomers, homodimers, 
heterodimers, or heterotrimers with cofactors such as Meis or Pbx family proteins (Moens 
and Selleri, 2006). Hox genes are highly conserved across species. In the nematode 
Caenorhabditis elegans, there are seven Hox genes in chromosome III that are distributed in 
intervals of 3.9 Mb. In the fly Droshophila melanogaster, eight Hox genes are clustered in 
chromosome 3R, which is referred to as the homeotic complex (HOM-C), and they are 
located across long interval regions consisting of 9.5 Mb. Hox genes are also clustered 
between 100 kb regions in the mammalian genome but this cluster is tandem duplicated; 
there are four clusters in the mouse (chromosomes 7, 17, 12, and 2) and humans 
(chromosomes 6, 11, 15, and 2). These separate clusters are termed Hox A, B, C, and D, 
respectively. 
In normal vertebrate development, there are three important features of Hox gene 
expression. First, the genomic locations reflect the expression in the A-P axis. Generally, 3’ 
genes are expressed in anterior tissues and 5’ genes in posterior tissues. This phenomenon is 
termed “spatial colinearity”. Second, 5’ located Hox genes will have a dominant phenotype 
to more 3’ located Hox genes. This is referred to as “posterior prevalence”. The third feature 
is “temporal colinearity”; 3’ located Hox genes in the cluster are expressed earlier than 5’ 
located Hox genes (Mallo et al., 2010). These properties are under strict expressional control; 
actually a wide range of factors are involved in the control of Hox gene expression. A 
common mechanism of regulation of Hox expression is epigenetic control. In general, the 
silencing of genes is mediated by histone modifications such as the methylation of the 
promoter region. Polycomb and trithorax group proteins are important modulators of 
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histone trimethylation. The polycomb group and trithorax complexes trimethylate lysine 27 
of histone H3 (H3K27) and lysine 4 of histone H3 (H3K4), respectively (Mendenhall and 
Bernstein, 2008). These histone modifications can be reflected in gene expression states such 
as inactive in H3K27m3 or active in H3K4m3. In undifferentiated pluripotent cells, two 
modifications are found in some local regions and are described as a bivalent chromatin 
domain (Bernstein et al., 2006). These chromatin modifications lead to changes in the 
accessibility of trans-acting factors that bind to cis-elements. The expression of Hox genes is 
regulated by a wide variety of trans-acting factors: Hox (self-, palalogus-, and another 
family gene) and other types of transcription factors (Cdx, Rar/Rxr, etc: see below). 
Second, small or large RNAs that are independent of protein synthesis regulate Hox gene 
expression. In the Hox cluster, there are three miRNA families, namely mir-10, mir-196, and 
mir-615. These miRNAs are conserved between the fly and humans. Generally, miRNAs 
have been thought to influence the target mRNA stability and translation. In mammalians, 
at least 30 of the 39 Hox 3’ UTRs have one or more conserved matches to miRNAs like mir-
196. The expression of these mir-10 and mir-196 families is complementary to Hox gene 
expression (Mansfield et al., 2004) and is closely linked to posterior prevalence (Hornstein et 
al., 2005; Yekta et al., 2004). The number of registered miRNAs has recently reached more 
than 16,000 (miRBase, release 17), suggesting that other miRNAs from outside the Hox 
cluster may contribute to the regulation of Hox gene expression. LncRNAs (long noncoding 
RNAs), which range from several hundred bases to dozens of kilobases, are another type of 
RNA polymerase II transcribed RNA with a different function from a template for protein 
synthesis. Xist, known as a regulator of parental-specific expression of imprinting genes, is 
cited as one example (Augui et al., 2011). There are two lncRNAs transcribed from both 
sides of the HoxA cluster. Hottip, transcribed from the 5’ site of HoxA13, and Hotairm1, 
transcribed from between HoxA1 and HoxA2, are the recently reported lncRNAs that lead to 
conformational changes in chromatin together with the transcribed Hox gene RNA (Rinn et 
al., 2007; Wang et al., 2011).  
The regulation of the expression of the Hox cluster genes occurs through a wide variety of 
mechanisms, and irregularities in this regulation can result in several abnormalities as 
described in the following sections.  
2.1.2 Phenotypes of Hox mutants 
Loss or gain of function Hox mutants show homeotic transformations across species. The 
identity of body segments is determined by specific combinations of Hox gene expression 
known as the “Hox-code”. Alterations in the Hox-code result in abnormalities in 
morphogenesis along the longitudinal (A-P) axis of the body, termed homeotic 
transformation. For example, loss of function of the labial gene in the fly, which is located in 
the 3’ region of the cluster, results in the disorganization of cranial structure, which is seen 
in the formation of the salivary glands. The antennapedia mutant is characterized by the 
replacement of antennae by legs (Hughes and Kaufman, 2002). The HOM-C complex is 
formed by two gene clusters, the antennapedia complex (ANT-C) and the bithorax complex 
(BX-C). These two complexes are encoded in the same chromosome but are separated by 9.5 
Mb. Genetic analyses have shown that ANT-C determines the specificity of the anterior 
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In higher organisms, there are 39 known Hox genes and the analysis of their function has 
become increasingly more complex. The analysis of the function of mammalian Hox genes in 
vivo has been carried out through the generation of a large number of Hox gene knockout or 
knock-in mice. These mice frequently show skeletal abnormalities such as alterations in the 
number of thoracic segments. These phenotypes are explained as resulting from aberrances in 
the Hox-code (Wellik, 2009). Dramatic phenotypes, such as the replacement of antennae by 
legs in the fly mutant, are not observed in single gene mutants in mammals possibly because 
of compensatory effects between the 39 Hox genes, especially among paralogous genes.  
Individual Hox genes have specific functions in various organs. Among skeletal 
abnormalities, cleft palate phenotypes have been detected in Hoxa2-/- mice (Gendron-
Maguire et al., 1993). These phenotypes have also been observed in Hoxa7 and Hoxb7 gain of 
function mice (Balling et al., 1989; McLain et al., 1992).  
The expression of Hox genes belonging to paralog groups 9 to 13 are coordinately detected 
during limb bud development. Among these genes, Hoxa13 and Hoxd13 in the paralog 
group 13 are specifically expressed in the developing distal region (the autopod). Human 
synpolydactyly (SPD) is a rare dominantly inherited limb malformation characterized by 
syndactyly between the third and fourth fingers and between the fourth and fifth toes. 
Typical SPD is caused by mutations of the Hoxd13 gene such as expansions, frame-shift 
deletions, and functional mutations (Malik and Grzeschik, 2008). Another human 
malformation, the hand-foot-genital syndrome (HFGS), is associated with mutations in the 
Hoxa13 gene (Goodman, 2002).  
In addition, aberrant limb formation has been observed in Hoxa13+/- and Hoxd13-/- mutant 
mice (Dolle et al., 1993; Fromental-Ramain et al., 1996). The greater severity of the 
phenotypes of Hoxa13+/-/Hoxd13-/- mice suggested that redundancies within paralog groups 
may play a role in limb development. These redundant manners are also observed in kidney 
formation. There are three Hox11 paralogous genes in clusters A, C, and D. In triple mutants, 
metanephric induction is completely absent, and the reduction of Six2 and Gdnf expression 
is believed to be one of the causative factors for this phenotype (Wellik et al., 2002). On the 
other hand, the activities of Hox genes within a single cluster are important for kidney 
formation (Di-Poi et al., 2007).  
Hoxa13-/-and Hoxd13-/- mice exhibit a reduction of branching in prostate ducts; Hoxa13-/- 
mutants die in utero with severe urinary and genital tract malformations (Podlasek et al., 
1999; Podlasek et al., 1997; Warot et al., 1997). Hoxb13 also functions in ventral prostate 
morphogenesis. Hoxb13-/- mice exhibit transparent ducts of the ventral prostate and these 
abnormalities are more severe in Hoxb13-/-/Hoxd13-/- mice, which show a 50% reduction in 
the number of duct tips (Economides and Capecchi, 2003). 
The involvement of the Hox genes described above in various morphogenetic events 
suggests the possible existence of a close relationship between Hox gene expression and the 
effects of teratogenic factors. 
2.1.3 Function of Hox genes: Proliferation, apoptosis, and differentiation 
Hox genes have different functions associated with proliferation, apoptosis, and 
differentiation. The Hox genes of the A, B, and C but not of the D clusters are transcribed in 
specific subpopulations during normal hematopoiesis. Gain- or loss-of-function analyses of 
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expressed Hox genes showed their ability to specifically regulate different stages of 
hematopoietic development. Among them, Hoxb4 serves as a positive regulator of self-
renewal and expansion (engraftment) in hematopoietic stem cells (HSC) (Antonchuk et al., 
2002; Kyba et al., 2002). On the other hand, definitive hematopoiesis was not disrupted in 
Hoxb4-deficient mice, but Hoxb3-/-/Hoxb4-/- mice exhibited more pronounced hematopoietic 
differences (Bjornsson et al., 2003; Sauvageau et al., 1995). These results suggest that a more 
complex mechanism, such as gene redundancy, compensatory mechanisms and cross-
regulatory interactions, among Hox genes may play a significant role in vivo. 
Hox genes are involved in the regulation of cell proliferation, and their expression in tumor 
cells has therefore been studied. Certain Hox genes show aberrant expression in various 
tumor cells (Shah and Sukumar, 2010). These disruptions of normal Hox expression may 
affect various pathways linked to the promotion of tumorigenesis and metastasis. Moreover, 
some Hox genes (Hoxa9, 11, and 13) are fusion partners of the nucleoporin gene Nup98 in 
human leukemia (Moore et al., 2007). This fusion oncoprotein may play a role in modulating 
transcription and controls the nucleo-cytoplasmic transport of some mRNAs and proteins. 
Actually, the Nup98-hox fusion induces myeloproliferative disease and AML in mouse bone 
marrow transplantation models. Other fusion proteins such as Hoxc11 or 13 are also known 
to induce AML.  
Tumorigenesis is often characterized by alterations in the balance between proliferation and 
apoptosis. When viewed from this perspective, alterations in Hox gene expression can 
contribute to tumorigenesis (oncogenesis) by allowing the activation or repression of the 
apoptosis pathway. In breast cancer cell lines, Hoxa5 directly regulates p53 expression by 
binding to its promoter (Raman et al., 2000). In addition, Hoxa5 induces apoptosis by 
promoting the expression of caspase 2 and caspase 8 in breast cancer cells in a p53-
independent manner (Chen et al., 2004). In the fly, Hox genes induce the localized cell death 
that is essential for the maintenance of a morphological boundary between the two 
structures of the embryo’s head, namely the maxillary and mandibular head lobes. In this 
case, the Hox gene Deformed (Dfd) directly activates the expression of the cell death 
promoting gene reaper (rpr), thereby inducing localized cell death (Lohmann et al., 2002). 
Although it is not clear whether this apoptotic pathway is conserved in mammalian cells, 
some Hox genes show a close relationship to the apoptosis pathway. 
Hox genes play crucial roles in differentiation. In HSC, the expression of Hox genes is 
downregulated during differentiation and maturation. The gain or loss of some Hox genes 
causes alterations in hematopoietic lineage commitment (He et al., 2011). Neural crest cells 
(NCCs) are also multipotent and can differentiate into different cell types, including 
peripheral and enteric neurons, glia, melanocytes, and smooth muscle. The Hox genes 
specify the location of the NCCs and contribute to the differentiation process (Minoux and 
Rijli, 2010).  
Recent observations indicated that some Hox genes also have multiple functions in higher 
order biological mechanisms. Grooming is a stereotypic behavior in mammals and energizes 
the various regions of the brain, such the brainstem, striatum, and cortex. Excessive 
grooming manifests itself in humans as the obsessive-compulsive spectrum disorder 
trichtilomania. Hoxb8 knockout mice show the excessive grooming phenotype. This 
abnormal behavior becomes a cause of death in knockout mice (Greer and Capecchi, 2002). 
Cell lineage tracing showed that this aberrant behavior can be attributed to the lack of bone 
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marrow-derived microglia cells (Chen et al., 2010). The reduction of the total number of 
microglia cells in the adult brain of Hoxb8 mutants is clear, although it remains unknown 
why the disruption of Hoxb8 function only affects a small fraction of microglia cells and 
whether Hoxb8 promotes the proliferation, differentiation or activation of apoptosis in a 
subpopulation of microglia cells.  
These results indicate Hox genes are involved in a wide range of biological functions. 
However, the role of these genes in various processes is not entirely clear and knowledge of 
the direct targets of Hox genes is quite limited. We identified Hox protein target genes using 
chromatin immunopurification (ChIP) (Tomotsune et al., 1993). The use of modified 
methods, such as ChIP-sequence, is necessary to obtain further information on target genes 
and to understand their mechanisms of action. 
2.2 Cdx family 
The Hox cluster is believed to have arisen through the duplication of an ancestral ProtoHox 
cluster in early metazoan evolution. In this process, the ParaHox cluster genes, which show 
close evolutionary relationships, also arose (Garcia-Fernandez, 2005). Cdx (caudal-type 
homeo-box) genes are ParaHox genes, and three paralogous Cdx genes are present in the 
mouse genome and are located in different chromosomes. Cdx genes are required to 
correctly pattern the head to tail axis.  
In Cdx1-/- mutants, an anterior homeotic transformation involving the occiput and the first 
three cervical vertebrae is observed. These changes are accompanied by a posterior shift of 
Hox expression involving three different clusters (Subramanian et al., 1995).  
Cdx2-/- mutants present a much more severe phenotype and die between E3.5 and E5.5. The 
embryonic lethality of these mutants may be attributed to aberrations in the maturation of 
trophoblasts from the trophoectoderm. Cdx2+/- animals are viable but show tail 
abnormalities and growth retardation. Anterior homeotic transformation in the lower 
cervical and upper thoracic regions is also observed in skeletal analyses 
(Chawengsaksophak et al., 1997).  
Cdx4 is an X-linked gene and no significant abnormality is observed in either sex in Cdx4-/- 
embryos (van Nes et al., 2006). However, double knockout Cdx1-/-/Cdx4-/() mice were 
reported to show alterations in skeletal structure, and Cdx2+/-/Cdx4-/() embryos were lethal 
around E10.5, which was attributed to a developmental defect of the chorio-allantoic 
placenta. 
Cdx2+/-/Cdx1-/- mutants show a greater degree of posterior truncation (van den Akker et al., 
2002). These results indicate the existence of redundancy in the Hox clusters among the Cdx 
family genes. The Cdx family genes directly regulate some Hox genes, such as Hoxa5 and 
Hoxb8 (Subramanian et al., 1995; Tabaries et al., 2005), as these Hox genes were shown to 
rescue the Cdx mutant phenotypes (Young et al., 2009). 
2.3 Another ParaHox gene 
Hox and ParaHox genes belong to the ANTP class of homeobox genes. The ANTP class also 
includes two other genes, Evx (even-skipped homeotic) and Meox (mesenchyme homeobox). 
These two ParaHox genes, Evx and Meox, are located on either side of the Hox cluster in 
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vertebrates. In the mouse genome, Evx and Meox each have two paralogous genes (Evx1, 
Evx2, and Meox1, Meox2) in different chromosomes. Evx1-/- is characterized by early 
embryonic lethality as it fails to differentiate extraembryonic tissues or to form egg cylinders 
(Spyropoulos and Capecchi, 1994). Evx2-/- mutants show malformation of the autopod, and 
these results indicate that Evx2 has a genetic interaction with Hoxd13 (Herault et al., 1996). 
Meox1-/- mutants exhibit hemi-vertebrae and rib, vertebral and cranial-vertebral fusions 
(Jukkola et al., 2005). Meox2-/- mutants show mild defects of rib and vertebral development 
(Mankoo et al., 1999). 
NK (Nirenberg and Kim) homeo-box genes are evolutionary relatives of both Hox and 
ParaHox genes. In the mouse genome, there are ten Nkx family genes that are located in 
seven different chromosomes. Nkx family genes are mostly observed in mesodermal 
derivatives; in particular, Nkx2.5 is essential for cardiac muscle differentiation (Hatcher et 
al., 2003). 
2.4 T-box family 
The T-box family genes encode a common DNA-binding domain known as the T-box and 
are also evolutionarily conserved transcription factors. This family of genes is composed of 
two independent functional domains: the T-box in the large N-terminal region and a 
transcriptional activation/repression domain in the C-terminal region. The Brachyury (or T) 
mouse mutant is characterized by a truncated tail and was discovered about 80 years ago. 
Until recently, 17 genes were identified as T-box family genes in vertebrates, and genetic 
analyses of individual genes have progressed significantly. These analyses indicate that T-
box genes are widely involved in developmental processes of mesoderm specification 
(Naiche et al., 2005). In humans, mutations in T-box genes, including deletions, 
rearrangements, missense mutations, insertions, and truncation, lead to various genetic 
disorders (Packham and Brook, 2003). The phenotypes of T-box gene knockout mice can be 
compared with the phenotypes of several human genetic disorders.  
Tbx1-/- mice have a lethal phenotype in late gestation and display a wide range of 
developmental abnormalities including facial abnormalities, cleft palate, cardiac outflow 
tract defects, and hypoplasia of the thymus and parathyroid glands (Jerome and 
Papaioannou, 2001; Merscher et al., 2001). In humans, chromosome 22q11 deletion 
syndrome is known as DiGeorge and velocardiofacial syndrome (DGS/VCFS) and its 
phenotypic characters include anomalies of the cardiac outflow tract, cleft palate, facial 
dysmophogenesis, and hypoplasia of the thymus and parathyroid glands. Tbx1 is located in 
a region spanning 3 Mb, but another genes are also located in this region. Tbx1 is thought to 
be a key gene in the etiology of DES/VCFS. 
Tbx3-/- mice show a deficiency of mammary gland induction, genital abnormalities, and 
forelimb and hind limb malformations, and die during gestation(Davenport et al., 2003). 
However, Tbx3+/- mice appear fairly unaffected. Ulnar-mammary syndrome (UMS) is a 
pleiotropic disease associated with malformations of the posterior elements of the upper 
limbs, apocrine/mammary hypoplasia and/or dysfunction, dental abnormalities, and 
genital anomalies. Clinical manifestations are highly variable. Many similarities are 
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Tbx4+/-mice form hind limb buds; however, they fail to outgrow them. Tbx4-/- mutants have 
problems with the allantoic connection to the placenta and die early in embryogenesis 
(Naiche and Papaioannou, 2003). The mutations in the human Tbx4 gene are linked to an 
autosomal dominant disorder called small patella syndrome (SPS) (Bongers et al., 2004). 
Tbx5-/- resulted in early embryonic lethality due to severe defects in early heart formation 
(Bruneau et al., 2001). Holt-Oram syndrome is an autosomal dominant disorder that 
includes cardiac and upper limb malformations. Tbx5+/- mutants faithfully recapitulate the 
human phenotype, including cardiac defects and forelimb malformations.  
As Tbx19 (known as Tpit) expression is restricted to the pituitary gland, Tbx19-/- mutants 
show a significant reduction in the number of pituitary POMC (pro-opiomelanocortin)-
expressing cells (Pulichino et al., 2003). In humans, the absence of pituitary POMC leads to a 
lack of adrenocorticotrophin (ACTH), resulting in adrenal insufficiency. 
The Tbx22-/- mutation caused death within 24 hr after birth due to submucous cleft palate 
and ankyloglossia (Pauws et al., 2009). In humans, Tbx22 is a gene responsible for X-linked 
cleft palate and ankyloglossia (Braybrook et al., 2001). 
3. Developmental toxicants 
Teratology is the study of abnormal development and congenital malformations attributed 
to genetic factors, maternal factors, toxicants, or other factors such as environmental 
chemicals. In the early 1970s, James G. Wilson created “The Six Principles of Teratology”. 
These principles are still applied today and guide the investigation of teratogenic agents and 
their effects on the development of organisms. A wide variety of chemicals and 
environmental factors are believed to have teratogenic potential in humans and animals. In 
the USA, the Food and Drug Administration (FDA) has categorized drugs into five different 
risk categories for pregnant women. These five categories (A, B, C, D, and X) have been 
considered a therapeutic advantage but they are only based on specific criteria and are not 
universal. Therefore, the number of these factors is likely higher than one thousand and is 
increasing daily. The teratogenic potentials of various chemicals and environmental factors 
are determined using animal models (e.g., zebra fish, mouse, rat, pig, rabbit, dog, and 
monkey). In the past, observations of the characteristics of embryos from candidate-exposed 
pregnant animals were used as the main criteria, but current teratological evaluations need 
to include knowledge about the molecular mechanisms. 
In this section, six xenobiotics known to be developmental toxicants in humans were 
selected for further description. 
3.1 Endocrine disruptors 
Under normal conditions, hormones are involved in the maintenance of homeostasis, but 
endocrine disruptors, which are environmental chemicals that have a hormone action or 
inhibit the activity of an endogenous hormone, have an adverse effect on organs and 
progeny. In adults, the role of the endocrine system in the maintenance of homeostasis is 
established and adults therefore have resistance against endocrine disruptors. However, in 
the fetus, infants, and children, resistance against these agents may be weak and they 
therefore can have irreversible impact on developmental functions such as organ formation. 
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Endocrine disruptors are found in low doses in products of daily use. DTT, polychlorinated 
biphenyls (PCBs), bisphenol A (BPA), polybrominated diphenyl esters (PBDEs), and a 
variety of phthalates are chemicals used in pesticides, plastic food containers or plastic toys, 
and are currently recognized as endocrine disruptors. 
Methoxychlor (MXC) is an organochlorine DDT derivative. MXC was shown to affect 
fertility in mice and cause maternal weight gain in fetal rats. These effects are thought to be 
mediated by the inhibition of estrogen binding to the Estrogen Receptor (Esr), by MXC and 
the suppression of the expression of Hoxa10 (Fei et al., 2005).  
BPA also affects estrogen signaling. In BPA-exposed males, an increase in the size of the 
prostate gland and oligospermia are observed. BPA exposure negatively regulates the 
expression of Hoxa10 and Hoxa11 and affects estrogen signaling (Varayoud et al., 2008).  
Estrogen and androgen are sex steroids that are needed for the proper development of 
reproductive organs (Dupont et al., 2000). Each steroid binds to a specific nuclear-receptor 
and these receptors act as ligand-dependent transcription factors. Alterations in Hox gene 
expression induced by endocrine disruptors is thus considered to be a nuclear receptor-
mediated mechanism. 
3.2 Diethylstilbestrol (DES) 
DES is a synthetic nonsteroidal estrogen. This chemical was used as a pharmaceutical 
product for the prevention of miscarriage in the 1970s, but vaginal cancer occurred 
frequently in children whose mothers took DES. Exposed offspring also experienced a high 
incidence of pregnancy wastage and preterm labor. DES induced altered Hox gene 
expression in human uterine endometrial and cervical cells. In reproductive organs, Hox 
genes are also expressed along the A-P axis. Under this rule, Hoxa9 is normally expressed in 
the oviduct and Hoxa10 in the uterus. However, this linear regulation of expression is 
disrupted in DES-exposed humans or mice, and the expressional domain is shifted 
posteriorly (Block et al., 2000). DES binds the Esr, and the irregular nuclear receptor 
activation may lead to aberrant Hox gene expression. 
3.3 Anticonvulsants (VPA) 
Valoproic acid (VPA) is a chemical compound used for the treatment of epilepsy. However, 
VPA has teratogenic potential along with other anticonvulsant drugs, including 
carbamazepine and phenytoin in humans. Having weak developmental toxicant of 
carbamazepine and phenytoin, VPA exposure is more toxicant. In humans, infants exposed 
to VPA in utero show anomalies including neural, craniofacial, cardiovascular, and skeletal 
defects. A similar teratology is exhibited in rodents, rabbits, and nonhuman primates. The 
spina bifida, a neural tube defect, is also observed in VPA-exposed infants at frequencies of 
1–2%. VPA exposed human embryonic carcinoma (NTera2/D1) cells show slight alterations 
in the expression of certain Hox genes (Faiella et al., 2000). VPA is also an inhibitor of class I 
and IIa HDACs (histone deacetylases); therefore, changes in the expressions of various 
genes are thought to occur in different tissues. However, it remains largely unknown why 
phenotypes appear only in limited organs in which HDAC is the primary target of VPA, 
and the mechanisms underlying the action of VPA are not clear. 
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Thalidomide (┙-phthaliidoglutarimide) was used as a sedative and for morning sickness in 
the late 1950s. However, reports of the teratogenic potency of thalidomide appeared in the 
early 1960s. In these reports, infants exposed to thalidomide during the early stages of 
pregnancy had multiple defects, such as malformations of the limbs, ears, eyes, internal 
organs and central nervous system. The most commonly observed defects were limb 
malformations including amelia (complete absence of the limb) and phocomelia (truncation 
or absence of the zeugopod). Thalidomide-induced limb defects are observed in humans, 
monkeys, rabbits and chicks, but these phenotypes are not observed in the mouse or rat 
(Vargesson, 2009). For 50 years, the mechanism of thalidomide-teratogenicity was poorly 
understood. Thalidomide is a derivative of glutamic acid and contains two imide rings: 
glutarimide and phthalimide. Thalidomide has therefore been believed to act by causing 
biochemical alterations of glutamic acid, nucleic acids and vitamin B. Recently, the primary 
target of thalidomide was identified and parts of the molecular mechanism were revealed 
(Ito et al., 2010). A thalidomide-binding protein, Cereblon (CRBN), forms an E3 ubiquitin 
ligase complex with Ddb1 and Cul4A in a thalidomide-dependent manner and modifies the 
expression of Fgf8 in the limb. Generally, the limb has three developmental axes: the 
proximal-distal axis, which runs from the base of the limb to the tip; the A-P axis, which 
runs parallel with the body axis; and the D-V axis, which runs from the back of the hand to 
the palm. Under the control of these three axes, various positional identities are specified by 
the concentration gradient of diffusible factors, such as Fgfs, Bmps, Wnt, and Sonic Hedgehog. 
The malformed fin or limb in knockdown Crbn zebrafish or the dominant negative form of 
Crbn expressing chicken, respectively, indicated the important role of the ubiquitin ligase 
pathway for morphogenesis through thalidomide, and clearly showed that the reduction of 
Fgf8 expression lead to the deformity of the limb. Although there is no information about 
the specific target molecule of Crbn, identification of this target molecule will allow a more 
effective use of thalidomide for the treatment of multiple myeloma and erythema nodosum 
leprosum and avoid its associated teratogenic risks. 
3.5 Retinoic acid 
In normal embryogenesis, a wide variety of diffusible factors act as morphogens and control 
proper morphogenesis. Retinoic acid is one of the morphogens that function during the 
formation of various organs such as the head, trunk, limbs, heart, and the central nervous 
system. Retinol and other retinoid compounds, which are precursors of retinoic acid, cannot 
be synthesized de novo and must therefore be ingested in food or supplements. After 
modification of ingested retinol by multiple enzymes, the resulting compounds bind to 
ligand-activated nuclear receptors, namely Rar (retinoic acid receptor) and Rxr (retinoid X 
receptor). Rar and Rxr are concurrently encoded by three family genes (┙, ┚, and ┛), and 
subtypes exist that are products of alternative splicing or different promoter usage. The 
activated nuclear receptors form homo- or hetero-dimers and recruit coactivators or 
corepressors to the RARE (retinoic acid response element) on the target genes. Some target 
genes have been identified and these genes function in the cell cycle, proliferation, and 
morphogenesis (Delacroix et al., 2010; Nielsen et al., 2008).  
Retinoids were found to be teratogenic in humans in the early 1980s. Infants exposed during 
gestation have teratogenic syndrome including craniofacial abnormalities and defects of the 
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thymic, cardiovascular, and central nervous system. The teratogenic effect is observed in 
other animal models, such as mouse, rat, pig, rabbit, dog, chick, and monkey. The dosage 
and timing of gestational exposure profoundly influence the form of the birth defect and the 
lethality, but differences in the genetic background in mice also have an effect. The peak 
period of sensitivity for a given tissue appears to be during the development of the 
primordial structures. 
Rar and Rxr knockout mice were produced by several methods and these mice exhibited 
various phenotypes (Mark et al., 2006). However, their abnormalities were restricted to a 
subset of tissues normally expressing these receptors, probably reflecting the existence of 
functional redundancies between nuclear receptors. The expression of certain Hox genes is 
controlled via RARE (Oosterveen et al., 2003). Although differences in the RA exposure 
dosage determine the phenotypes, aberrant Hox gene expression is thought to play a role in 
the morphological malformations. 
3.6 Dioxin 
PCDDs (polychlorinated dibenzo-p-dioxins), PCDFs (polychlorinated dibenzofurans) and 
DL-PCBs (dioxin-like polychlorinated biphenyls) are generically termed as dioxin and are 
similar toxicants. Dioxin is an environmental contaminant and is unintentionally generated as 
a by-product of industrial combustion. Among dioxins, TCDD (2, 3, 7, 8-Tetrachlorodibenzo-p-
dioxin) is the most severe toxicant and has the highest teratogenic potency in mammals. 
Differences in the exposure dosage determine the resulting phenotypes, which include cleft 
palate, hydronephrosis, and defects of sex organs. There are differences due to timing and 
dose of exposure, TCDD exposure causes a significant decrease in ventral prostate 
development, which is similar to the effect of impairment of certain Hox genes (Vezina et al., 
2009), but the correlativity between TCDD and Hox expression is not cleared. 
The molecular mechanisms of the xenobiotic dioxin pathway can be understood through the 
analyses of nuclear receptors. The toxicant and teratogenic effects of dioxin are thought to 
depend on the activation of the Ahr (aryl hydorocarbon receptor) pathway. Ahr has 
multiple functions. Ahr is a ligand-activated transcription factor that is a member of the 
bHLH/PAS (basic Helix-loop-Helix/Per-Arnt-Sim) family of genes. Ahr generally localizes 
to the cytoplasm and forms a complex with Hsp90 (heat shock protein 90), cochaperone p23, 
and the immunophilin-like protein Ara9 (Bell and Poland, 2000). Upon binding ligand, Ahr 
is released from the p23/Ara9 complex and translocates to the nucleus. In the nucleus, Ahr 
dissociates from Hsp90 and dimerizes with another bHLH-PAS family gene, Arnt (Ahr 
nuclear translocator). The Ahr/Arnt heterodimer binds to specific DNA sequences termed 
XREs (xenobiotic response elements: 5’-GCGTG-3’) and regulates target gene expression 
with transcriptional coactivators/corepressors, which are also partners of Rar/Rxr 
(Beischlag et al., 2002). Currently, various genes are reported as Ahr target genes: phase I 
drug metabolizing enzymes, such as those of the Cyp450 (Cytochorome 450) family; phase II 
enzymes, such as Ugt1a1 (Kohle and Bock, 2007); and as down stream genes of Ahr-
pathway, such as cytokines, and Tgf family which are unrelated xenobiotic metabolism 
genes (Haarmann-Stemmann et al., 2009).  
Ahr is also a modulator of estrogen receptor signaling. Ohtake et al. indicated that the 
ligand-activated Ahr/Arnt heterodimer directly associates with the Esr, recruits a 
coactivator, and regulates the expression of Esr target genes (Ohtake et al., 2003). In this 
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case, Ahr functions as activator/repressor depending on the ligand binding state of the Esr. 
Another function of ligand-activated Ahr as a substrate-specific adaptor in the Cullin 4B 
ubiquitin ligase complex was described (Ohtake et al., 2007). In this case, agonist (3MC: 3-
methylcholanthrene)-activated Ahr ubiquitinates Esr1 and androgen receptor (Ar) in vitro 
and in vivo. In Ahr-deficient mice, responses to dioxin such as the induction of Cyp1a1 
activation were not observed. However, null mutants have functional impairments of male 
and female reproductive organs, depending on the affected allele (Schmidt et al., 1996). 
Although there are other identified ligands for Ahr, including flavonoids, UV photo-
products of tryptophan and some synthetic retinoids, the above observations suggest that 
Ahr plays a role in the cross talk between the dioxin and RA pathways. 
4. Hox-RA/dioxin 
The identification of molecular markers for the variety of existing teratogenic factors is an 
urgent need in various respects. In the present report, we focused on the expressional 
changes of the Hox cluster genes in embryos exposed to teratogenic factors because their 
aberrant expression lead to various morphological defects and the affected animals have 
close similarities (Kojima and Takahashi, 2009).  
Because the different amount and timing of exposure to teratogenic factors are correlated to 
the different effects in embryos, we firstly examined the RA or dioxin effects in E10.5 
embryos for 6 hr by one-shot administration. This dose induced craniofacial and skeletal 
defects in RA-exposed embryos, and hydronephrosis in dioxin-exposed embryos. Among 39 
Hox cluster genes, 3’-located paralogs (Hox1~8) were up-regulated and some 5’-located 
genes (Hoxa11, Hoxd9, and Hoxd12) were down-regulated in the RA-exposed embryos (Fig. 
1). Meanwhile, the influence of relative position in the cluster was not observed in the 
TCDD-exposed embryos. A and D cluster genes were down-regulated and no clear 
difference was observed in the cluster B. Additionally, aberrant expression of pri-miRNAs 
(precursors of miRNAs) was detected (Fig. 2). These pri-miRNA changes were correlated 
with changes in the expression of closely located Hox genes.  
TCDD exposure causes a decrease in the levels of all-trans RA in the liver, which is the main 
RA storage location in a variety of species (Fletcher et al., 2001). There are some similarities 
in terms of morphological changes between RA- and TCDD-exposed embryos. The 
developmental effects of the replacement of RA storage by TCDD are not clear, but it is 
suggested that TCDD and related compounds have an impact on retinoid homeostasis and 
the RA signaling pathway. Our analyses indicate that alterations in the expression of Hox 
cluster genes do not show a clear correlation with these teratogenic factors. In addition, 
expressional changes of some pri-miRNAs in the Hox clusters are also different between 
these two factors. Although the involvement of Ahr in the cross talk between the RA and 
TCDD pathways is possible, there are clear differences in the downstream effects, such as 
expressional changes of Hox cluster genes. We also detected changes in the expression of 
other transcription factors, such as ParaHoxs and T-box family genes, in embryos exposed to 
these factors. Some genes show a specific response to each teratogenic factor. Based on these 
results, changes in the expression of transcription factors can be considered as potential 
molecular markers for the verification of teratogenic effects. Therefore, to better determine 
the teratogenic potential of various chemicals, further investigation of the effects of the 
timing or dosage of RA and TCDD in exposed embryos is under way. 
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Fig. 1. Expressional changes of the Hox cluster genes in embryos treated with teratogenic 
agents. 39 Hox genes are separated on four clusters (A, B, C, and D) in four chromosomal 
loci. The box indicates each gene. Red boxes indicate up-regulated and blue boxes indicate 
down-regulated genes in response to treatment with teratogenic agents. 
 
 
Fig. 2. Expressional changes of pri-miRNAs in the Hox cluster genes. Three miRNA family 
genes (miR-196, miR-10, and miR-615) are located in the Hox cluster. Red arrows indicate RA 
and the blue arrow indicates TCDD exposure. The upward direction of the arrow represents 
increased expression and the downward direction represents decreased expression. 
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Contrasting a comprehensive analysis using DNA microarrays, our analysis is simpler and 
allows the examination of a large number of samples. Information on molecular markers 
such as the Hox genes under various conditions (exposure-time, -dosage) will allow the 
prediction of the hazardous nature of unknown factors. In addition, the understanding of 
the molecular mechanisms common to different teratogenic agents requires the 
identification of the target genes of Hox protein and each transcription factor and an 
understanding of transcription factor networks. 
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